Paula O’Leary and Fergus Shanahan University College Cork, Cork, Ireland Immunodeficiency disorders are a heterogeneous group of conditions that may be classified broadly into primary and secondary syndromes. Selective immunoglobulin A (IgA) deficiency and common variable immunodeficiency (CVID) (Figures 68.1 and 68.2) are the most common primary immunodeficiency syndromes among adults. Secondary immunodeficiencies are much more common than primary disorders. Causes include malnutrition, infection (HIV), protein‐losing enteropathy such as intestinal lymphangiectasia (Figure 68.3), cancer, and iatrogenic immunosuppression. The gastrointestinal tract is a primary target organ in both primary and secondary immunodeficiency disorders because of its large surface area and constant exposure to environmental pathogens. The gut mucosa is composed of the single largest collection of lymphoid tissue in the body, primed to respond effectively to microbial challenge while at the same time regulated closely to avoid inappropriate and potentially harmful immune responses to the extensive and varied exposures experienced at this host–environment interface. The principal gastrointestinal consequence of immunodeficiency is increased susceptibility to infection. This includes infection with unusual agents, atypical manifestations of infection with commonly encountered pathogens, and bacterial overgrowth with organisms normally present in the gastrointestinal tract. There is also an increased prevalence of autoimmune disorders or chronic inflammatory conditions such as atrophic gastritis, inflammatory bowel disease, and celiac disease. In some immunodeficiency states, there is an increased incidence of malignant tumors, particularly lymphoma. Benign diffuse nodular lymphoid hyperplasia may occur among some patients, whereas lymphoid atrophy may be a feature among others. Patients with severe immunodeficiency may have graft‐versus‐host disease caused by transplacentally acquired maternal lymphocytes or unintentional transfusion of nonirradiated blood products. However, patients with mild or selective forms of immunodeficiency, such as selective IgA deficiency, frequently are free of infections or other manifestations. Diffuse nodular lymphoid hyperplasia occurs among approximately 20% of patients with CVID. The lymphoid nodules are in the lamina propria and submucosa and produce a nodularity that is visible on radiographic studies and at endoscopy (Figure 68.4). They are most prevalent in the small bowel, in some cases extend into the colon, and rarely extend into the stomach. At microscopic examination, the nodules consist of large lymphoid follicles with germinal centers (Figure 68.5). Plasma cells are usually absent. Lymphoid hyperplasia is believed to be caused by proliferation of B cells that are unable to undergo full differentiation to immunoglobulin secretion and therefore are unresponsive to feedback regulation of proliferation.
CHAPTER 68
Gastrointestinal manifestations of immunological disorders
Immunodeficiency
Nodular lymphoid hyperplasia